| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 02/10/2005 | WO2005012263A1 5-ht2b receptor antagonists |
| 02/10/2005 | WO2005012262A1 2-aminophenyl-4-phenylpyrimidines as kinase inhibitors |
| 02/10/2005 | WO2005012256A1 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators |
| 02/10/2005 | WO2005012252A1 Novel 6-phenylphenantridines |
| 02/10/2005 | WO2005011703A1 2-cyano-1,3,5-triazine-4,6-diamine derivatives |
| 02/10/2005 | WO2005011700A1 INHIBITORS OF Akt ACTIVITY |
| 02/10/2005 | WO2005011697A2 Sulfonamide derivatives with activity on protein kinase a and b |
| 02/10/2005 | WO2005011681A1 Chemical compounds |
| 02/10/2005 | WO2005011675A1 Derivatives of 3-hydroxy-pyrrole-2,4-dicarboxylic acid and uses thereof |
| 02/10/2005 | WO2005011611A2 Bicyclic compounds and compositions as pdf inhibitors |
| 02/10/2005 | WO2005011592A2 Substituted indazole-o-glucosides |
| 02/10/2005 | WO2005011581A2 Hexahydrodiazepinones as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 02/10/2005 | WO2004093856A3 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia |
| 02/10/2005 | WO2004060305A3 Anti-cancer medicaments |
| 02/10/2005 | WO2004054507A3 Indolizine compounds |
| 02/10/2005 | WO2003099793A9 1,2-azole derivatives with hypoglycemic and hypolipidemic activity |
| 02/10/2005 | US20050033056 Hydroxylated indole derivatives and uses thereof |
| 02/10/2005 | US20050032869 Antitumor, anticarcinogenic, antiproliferative, and antimetastasis agents; tyrosine kinase inhibitors; autoimmune, nervous system, neurodegenerative, and skin disorders; neurofibromatosis, atherosclerosis, graft versus host disease, glomerulonephritiis, hyperplasia; angiogenesis inhibitors |
| 02/10/2005 | US20050032868 Selected substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonists |
| 02/10/2005 | US20050032866 Administering N-[(1-butyl-4-piperidinyl)methyl]-3,4-dihydro-2H-[1,3]oxazino[3,2-a]indole-10-carboxamide or salt as antiarrhythmia agent |
| 02/10/2005 | US20050032851 E. g.,N-[[4-[2-(5-Methylpyridin-3-yl)-4-(trifluoromethyl)-1H-imidazol-1-yl]phenyl]sulfonyl]acetamide; side effect reduction; non-steroidal antiinflammatory agents; antiarthritic agents; analgesics; antipyretics; acylation of the corresponding sulfoamide by an anhydride a solvent and base |
| 02/10/2005 | US20050032847 Enzyme inhibitors of nitric oxide synthase; central nervous system disorders; analgesics; cardiovascular disorders; headaches; antiinflammatory, -carcinogenic and -ulcer agents; stroke; analgesics; shock; reperfusion injury; Crohn's and Alzheimer's and neurodegenerative diseases; multiple sclerosis |
| 02/10/2005 | US20050032842 Omeprazole Form A characterized in being being more thermodynamically stable at room temperature and less hygroscopic than omeprazole Form B; heat resistance; photostability; crystallization of a dissolved omeprazole of any form; gastrointestinal disorders; antiulcer agents; campylobacter infections |
| 02/10/2005 | US20050032838 Nicotinamide derivatives useful as PDE4 inhibitors |
| 02/10/2005 | US20050032837 For therapy of irritable bowel syndrome, drug addiction or dependency, including alcohol addiction, depression, anxiety, schizophrenia, anxiety, schizophrenia and eating disorders |
| 02/10/2005 | US20050032821 2-etherified 4-fluoroalkyl-6-(p-sulfonylphenyl)pyrimidines,e.g., 2-(4-fluorophenoxy)-4-[4-(methylsulfonyl)phenyl]-6](trifluoromethyl)pyrimidine; treatment of the pain, fever and inflammation of variety of conditions and diseases |
| 02/10/2005 | US20050032819 Quinazolinone derivative |
| 02/10/2005 | US20050032816 N-oxide anthranylamide derivatives and their use as medicaments |
| 02/10/2005 | US20050032814 Process for production of cyclic diamine compounds or salts thereof |
| 02/10/2005 | US20050032810 Novel anthelmintic and insecticidal compositions |
| 02/10/2005 | US20050032809 5-HT receptor ligands and uses thereof |
| 02/10/2005 | US20050032805 Antimicrobial biaryl compounds |
| 02/10/2005 | US20050032800 4-Substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them |
| 02/10/2005 | US20050032798 Diaryl ureas, which release urea compound when administered to patient, for example, 1-(4-chloro-3(trifluoromethyl)phenyl)-3-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)-2-oxo-(1,3,5-perhydrotriazapine); treatment of cancer, inflammation |
| 02/10/2005 | US20050032797 Fluorinated di-aryl urea compounds |
| 02/10/2005 | US20050032792 Peptidyl spiroheterocyclic, amidino and guanidino compounds; reversible inhibitors of the cysteine protease cathepsin S, K, F, L and B; useful in the treatment of autoimmune and other related diseases |
| 02/10/2005 | US20050032791 Derivatives of sulphonamides, their preparation and use as medicaments |
| 02/10/2005 | US20050032790 For example, 1-(2-Amino-4-chlorobenzoyl-D-phenylglycinyl)-4,4'-bispiperidine; for treatment of thrombosis, emphysema, cirrhosis; antiarthritic agents, anticancer agents, antihistamines |
| 02/10/2005 | US20050032772 Compounds useful as reversible inhibitors of cysteine proteases |
| 02/10/2005 | US20050032711 Antidiabetic agents; insulin resistance |
| 02/10/2005 | US20050031899 Carbazole derivative, organic semiconductor element, light emitting element, and electronic device |
| 02/10/2005 | US20050030912 Use of hybrid (HW/DSP/MCU/SW) architectures for powerline OFDM communication field |
| 02/10/2005 | US20050028300 Use of tetra-azapentamethine compounds as direct dyeing agents and novel tetraazapentamethine compounds |
| 02/10/2005 | CA2549017A1 Substituted indazole-o-glucosides |
| 02/10/2005 | CA2534649A1 Bicyclic imidazol derivatives against flaviviridae |
| 02/10/2005 | CA2534212A1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 02/10/2005 | CA2534038A1 Inhibitors of akt activity |
| 02/10/2005 | CA2533893A1 Hexahydrodiazepinones as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 02/10/2005 | CA2533824A1 Bicyclic compounds and compositions as pdf inhibitors |
| 02/10/2005 | CA2533684A1 Substituted pyridones and pyrimidinones with antiinflammatory properties |
| 02/10/2005 | CA2533635A1 Novel 6-phenylphenantridines |
| 02/10/2005 | CA2533474A1 2-aminophenyl-4-phenylpyrimidines as kinase inhibitors |
| 02/10/2005 | CA2533363A1 3-amino choman and 2-amino tetralin derivatives |
| 02/10/2005 | CA2533345A1 Piperidyl-quinazoline derivatives as tyrosine kinase inhibitors |
| 02/10/2005 | CA2532965A1 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators |
| 02/10/2005 | CA2532505A1 5-ht2b receptor antagonists |
| 02/09/2005 | EP1505067A1 4,4-disubstituted piperidine derivatives having ccr3 antagonism |
| 02/09/2005 | EP1505066A1 Polymorph of acid 4-[2-[4-[1-(2-ethoxyethyl)-1h-benzimidazole-2-il]-1-piperidinyl]ethyl]-alpha, alpha-dimethyl-benzeneacetic |
| 02/09/2005 | EP1505063A1 Benzimidazole derivatives |
| 02/09/2005 | EP1505062A1 Heterocyclic derivatives and their use as antithrombotic agents |
| 02/09/2005 | EP1505061A1 Compound exhibiting pgd 2 receptor antagonism |
| 02/09/2005 | EP1504008A1 7-aminoimidazotriazones |
| 02/09/2005 | EP1504001A1 2-(2-pyridyl)-5-phenyl-6-aminopyrimidine, method and intermediate products for the production and use thereof for combating noxious fungi |
| 02/09/2005 | EP1503996A1 Aryl ketone pyrrolo-triazine compounds useful as kinase inhibitors |
| 02/09/2005 | EP1503994A1 Substituted (thioxo)carbonylamino phenyl uraciles |
| 02/09/2005 | EP1503992A1 Pyridazin-3(2h)-one derivatives as pde4 inhibitors |
| 02/09/2005 | EP1503991A1 Hexahydro-pyridazine-3-carboxylic acid derivatives, pharmaceutical compositions containing same and preparation methods thereof |
| 02/09/2005 | EP1503990A1 Active substances for the treatment, diagnosis and prophylaxis of diseases in which abnormal protein structures occur |
| 02/09/2005 | EP1503988A2 Fredericamycin derivatives |
| 02/09/2005 | EP1503986A2 Compositions and methods for treating heart failure |
| 02/09/2005 | EP1503981A2 Substituted tetracycline compounds |
| 02/09/2005 | EP1503762A2 Novel crystalline forms of gatifloxacin |
| 02/09/2005 | EP1503761A1 Substituted piperazines as melanocortin receptor ligands |
| 02/09/2005 | EP1503759A2 Substituted quinolone carboxylic acids, their derivatives, site of action, and uses thereof |
| 02/09/2005 | EP1503757A2 Tyrosine kinase inhibitors |
| 02/09/2005 | EP1503754A1 Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders |
| 02/09/2005 | EP1430047B1 Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same |
| 02/09/2005 | EP1430034B1 Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same |
| 02/09/2005 | EP1204322B1 Fungicides |
| 02/09/2005 | EP1105376B1 Oxindole derivatives as growth hormone releasers |
| 02/09/2005 | EP1042316B1 Indole derivatives useful a.o. for the treatment of osteoporosis |
| 02/09/2005 | EP0934310B1 Thio acid derived monocyclic n-heterocyclics as anticoagulants |
| 02/09/2005 | CN1578773A Methods and compositions of novel triazine compounds |
| 02/09/2005 | CN1578767A Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient |
| 02/09/2005 | CN1578665A Type 4 phosphodiesterase inhibitors and uses thereof |
| 02/09/2005 | CN1578663A Inhibitors of histone deacetylase |
| 02/09/2005 | CN1578660A Lactam-containing compounds and derivatives thereof as factor xa inhibitors |
| 02/09/2005 | CN1578659A Modulators of peroxisome proliferator activated receptors (ppar) |
| 02/09/2005 | CN1576275A Substituted bicyclic derivatives for the treatment of abnormal cell growth |
| 02/09/2005 | CN1575816A Compounds for the treatment of female sexual dysfunction |
| 02/09/2005 | CN1188415C Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3', 5'-monophosphate phosphodiesterase (cGMP PDE5)for treatment of sexual dysfunction |
| 02/09/2005 | CN1188407C Imidazole derivatives with farnesyl transferase to inhibite activity and preparing method thereof |
| 02/09/2005 | CN1188402C Piperazinone derivs. and their uses |
| 02/09/2005 | CN1188397C Process for preparation of acid chloride compounds |
| 02/08/2005 | US6852814 Thermosetting resin compositions containing maleimide and/or vinyl compounds |
| 02/08/2005 | US6852752 Urea compounds, compositions and methods of use and preparation |
| 02/08/2005 | US6852745 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 02/08/2005 | US6852742 To modulate the activity of calcium channels, therapy of cardiovascular disease or neurological disorders, that are associated with calcium channels |
| 02/08/2005 | US6852740 Treating p38 kinase mediated disorders. Compounds of particular interest are defined by Formula I Mitogen-activated protein kinases (MAP) is a family of proline- directed serine/threonine kinases that activate their |
| 02/08/2005 | US6852739 Novel nitrosated and/or nitrosylated proton pump inhibitor compounds, and novel compositions comprising at least one proton pump inhibitor compound that is optionally substituted with at least one NO and/or N02 group, and, optionally, at |